SCHEMBL13699835

SCHEMBL13699835

COCC(=O)Nc1c(C(N)=O)oc2ccc(Cl)cc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.70
MAPK1 P28482 2/20 0.58
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 4/20 0.53
HPGD P15428 4/20 0.53
HSD17B10 Q99714 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
TEAD1 P28347 1/20 0.51
YAP1 P46937 1/20 0.51
TEAD4 Q15561 1/20 0.51
TEAD2 Q15562 1/20 0.51
ATM Q13315 1/20 0.50
MAPT P10636 4/20 0.48
LMNA P02545 1/20 0.48
TSHR P16473 2/20 0.47
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
RAB9A P51151 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699842 0.86 KDM4E (0.63) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL13699834 0.86 KDM4E (0.51) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL1852546 0.85 KDM4E (0.72) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL13699837 0.84 KDM4E (0.61) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL13699841 0.82 KDM4E (0.58) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL4250076 0.82 KDM4E (1.00) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL13699791 0.81 KDM4E (0.66) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL4251378 0.79 HPGD (0.58) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL13699795 0.78 HPGD (0.75) KDM4EMAPK1KMT2AMEN1ALDH1A1
SCHEMBL4260294 0.78 KDM4E (0.53) KDM4EALDH1A1TEAD1YAP1TEAD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885MAPK1 3982/4885KMT2A 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.